Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7132195 | 0.82 | ALDH1A1 (0.38) | NPC1RAB9A | |
| SCHEMBL23536852 | 0.80 | ALDH1A1 (0.37) | NPC1RAB9A | |
| SCHEMBL8545819 | 0.69 | SLC1A3 (0.35) | — | |
| SCHEMBL28478305 | 0.68 | CES2 (0.42) | NPC1RAB9A | |
| SCHEMBL10959754 | 0.67 | NPC1 (0.40) | NPC1 | |
| SCHEMBL28380002 | 0.65 | CES2 (0.39) | NPC1RAB9A | |
| SCHEMBL5150393 | 0.65 | KMT2A (0.40) | NPC1RAB9A | |
| SCHEMBL5284629 | 0.64 | ALDH1A1 (0.39) | — | |
| SCHEMBL14813391 | 0.64 | NPC1 (0.38) | NPC1 | |
| SCHEMBL2331142 | 0.63 | ALDH1A1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6670512-B2 | Molecular templates for metal complexation | STRYKER JEFFREY MARK (CA) | 2003-12-30 | — | — | US | disclosed |
| US-20020183540-A1 | Substituted tetraarylethylene compounds | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA | 2002-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183540-A1 | Substituted tetraarylethylene compounds | ABL1, ETV6, ALK | NPC1 517/4885RAB9A 1308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.